SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Addiction Medicine Consultation — Judy Garland

PatientJudy Garland
Date of birth1993-06-10
IdentifiersMRN HR-ML005-SYN; SSN (made up) 000-05-6127
Document date2026-06-29
AuthorTobias Grünewald, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Long-term dependence on prescribed secobarbital and dextroamphetamine that began with pills given to her as a teenage performer, in a 33-year-old singer three months after childbirth, with depression and anxiety. Please confirm the diagnoses and advise on a safe way to withdraw the barbiturate and stop the stimulant. [S]

Urgency: Within one week, on the same day as her one-week primary care visit. [S]

Questions for the consultant:

History of Present Illness

Ms. Garland, a 33-year-old singer and actor, is seen at the request of Dr. Ellsworth-Diaz. She was given pills for energy and sleep from her early teens and has taken them ever since. For years she has taken secobarbital 200 mg at bedtime, and up to 300 mg before important days, and dextroamphetamine each morning with extra tablets on long working days. In the past week, on a single prescriber and seven-day supplies, she took 200 mg on six nights and 300 mg on one, and dextroamphetamine 10 mg each morning. She has tried to stop on her own several times and could not sleep for days. She has never had a seizure. She feels ashamed and wants to stop. She has two weeks free of performances starting next week. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Secobarbital 100 mg oral capsule, two capsules (200 mg) at bedtime; prescribed elsewhere for years; continued by this clinic at the verified dose, seven days at a time, until a supervised withdrawal is planned with addiction medicineTwo capsules at bedtime; no extra dosesOral route2026-06-22 to 2026-07-06completedS
Dextroamphetamine 10 mg oral tablet, one tablet each morning; no extra doses; prescribed elsewhere for weight and energyOne tablet each morningOral route2026-06-22 to 2026-07-20completedS
Sertraline 25 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-06-22 to 2026-06-29completedS
Sertraline 50 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-06-29activeS
Medroxyprogesterone acetate 150 mg/mL injection, 150 mg into the muscle every 13 weeks150 mg intramuscularly every 13 weeksIntramuscular route2026-06-22activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Sedative, hypnotic, or anxiolytic use disorder (barbiturate), moderate, with physiological dependence; began with sleeping pills given in adolescence; synthetic modern episode linked to her documented lifelong dependence on prescribed sleeping pillsactiveconfirmed F13.20S — Synthetic modern coding. Tolerance and withdrawal are not counted toward the diagnosis for a medicine taken under medical supervision; five other criteria are met. Person-first language; not a claim about her real diagnosis.
Stimulant use disorder (prescribed amphetamine), mild; began with stimulants given in adolescence for weight and energy; synthetic modern episode linked to her documented pep pillsactiveconfirmed F15.10S — Synthetic modern coding; DSM-5-TR mild stimulant use disorder maps to F15.10. Tolerance and withdrawal are not counted for a supervised prescription.
Chronic insomnia disorder, long-standing, with sleep tied to sleeping pills since adolescenceactiveconfirmed G47.00S — Synthetic modern diagnosis anchored to the documented sleeping pills.
Contraception three months after childbirth while starting an enzyme-inducing drug: injectable progestin chosen because barbiturates, including any used for the withdrawal, weaken contraceptive pills, patches, rings and implantsactiveconfirmed Z30.013S — Synthetic contraception need; the birth is documented.
Major depressive disorder, single episode, moderate, with anxious distress; Mood Disorder Questionnaire negative and no history of mania or hypomaniaactiveconfirmed F32.1S — Synthetic modern diagnosis; not a claim about her real mood. The roster's bipolar disorder lead is not supported by the sources read and is not used.

Physical Exam

Vital signs recorded on 2026-06-29; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralAlert; blood pressure 124/80, pulse 92
NeurologicalNo tremor; no nystagmus; gait steady
PsychiatricEngaged and candid; anxious; no signs of intoxication or withdrawal

Assessment

Data reviewed: Dr. Ellsworth-Diaz's intake note, safety assessment, DAST-10 6, AUDIT-C 2, PHQ-9 14, GAD-7 13 and negative Mood Disorder Questionnaire. Prescription drug monitoring program: three prescribers and two pharmacies before intake, only this clinic since. Urine drug test at intake: barbiturates and amphetamine only. Last week's results: hemoglobin 12.3 g/dL, platelets 284, sodium 139, potassium 4.1, creatinine 0.66 mg/dL, eGFR 119, glucose 82 mg/dL, AST 21, ALT 18 and GGT 24 U/L, TSH 1.9 mIU/L, ferritin 24 ng/mL. ECG: sinus rhythm, QTc 428 ms. [S]

Plan of Treatment